ES3060334T3 - Detecting hematological disorders using cell-free dna in blood - Google Patents

Detecting hematological disorders using cell-free dna in blood

Info

Publication number
ES3060334T3
ES3060334T3 ES23214529T ES23214529T ES3060334T3 ES 3060334 T3 ES3060334 T3 ES 3060334T3 ES 23214529 T ES23214529 T ES 23214529T ES 23214529 T ES23214529 T ES 23214529T ES 3060334 T3 ES3060334 T3 ES 3060334T3
Authority
ES
Spain
Prior art keywords
dna
methylation
plasma
cell
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES23214529T
Other languages
English (en)
Spanish (es)
Inventor
Yuk-Ming Dennis Lo
Rossa Wai Kwun Chiu
Kwan Chee Chan
Kun Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinese University of Hong Kong CUHK
Original Assignee
Chinese University of Hong Kong CUHK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinese University of Hong Kong CUHK filed Critical Chinese University of Hong Kong CUHK
Application granted granted Critical
Publication of ES3060334T3 publication Critical patent/ES3060334T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Evolutionary Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ES23214529T 2016-05-30 2017-05-30 Detecting hematological disorders using cell-free dna in blood Active ES3060334T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662343050P 2016-05-30 2016-05-30

Publications (1)

Publication Number Publication Date
ES3060334T3 true ES3060334T3 (en) 2026-03-25

Family

ID=60479040

Family Applications (1)

Application Number Title Priority Date Filing Date
ES23214529T Active ES3060334T3 (en) 2016-05-30 2017-05-30 Detecting hematological disorders using cell-free dna in blood

Country Status (13)

Country Link
US (3) US10781490B2 (https=)
EP (3) EP3885447B1 (https=)
JP (3) JP6987393B2 (https=)
KR (4) KR20260023093A (https=)
CN (2) CN109196120B (https=)
AU (2) AU2017274038B2 (https=)
CA (1) CA3025708A1 (https=)
DK (2) DK3885447T3 (https=)
ES (1) ES3060334T3 (https=)
IL (2) IL303115B2 (https=)
SG (1) SG11201810544WA (https=)
TW (2) TW202426661A (https=)
WO (1) WO2017206888A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI813141B (zh) 2014-07-18 2023-08-21 香港中文大學 Dna混合物中之組織甲基化模式分析
EP3885447B1 (en) 2016-05-30 2024-01-10 The Chinese University Of Hong Kong Detecting hematological disorders using cell-free dna in blood
KR20260032575A (ko) 2016-11-30 2026-03-09 더 차이니즈 유니버시티 오브 홍콩 소변 및 기타 샘플에서의 무세포 dna의 분석
SG11201906397UA (en) 2017-01-25 2019-08-27 Univ Hong Kong Chinese Diagnostic applications using nucleic acid fragments
CN111051536A (zh) 2017-07-26 2020-04-21 香港中文大学 利用不含细胞的病毒核酸改善癌症筛选
WO2019173283A1 (en) 2018-03-05 2019-09-12 Marquette University Method and apparatus for non-invasive hemoglobin level prediction
US12098429B2 (en) 2019-03-25 2024-09-24 The Chinese University Of Hong Kong Determining linear and circular forms of circulating nucleic acids
CN110361531B (zh) * 2019-08-02 2023-04-11 天津医科大学总医院 一种检测微粒促凝活性的实验方法
CN115175985A (zh) * 2019-12-20 2022-10-11 威廉马歇莱思大学 从未经处理的生物样本中提取单链dna和rna并测序的方法
GB2598272A (en) * 2020-03-19 2022-03-02 Schreier Stefan Means and method for detecting aberrant erythroblasts
EP3905260A1 (en) * 2020-04-28 2021-11-03 Sysmex Corporation Method, apparatus and system for testing blood
CN111518876B (zh) * 2020-05-11 2023-01-13 润方(北京)生物医药研究院有限公司 一种牛血红蛋白制品中牛源基因组dna定量检测方法及其应用
KR102517894B1 (ko) * 2021-02-23 2023-04-04 연세대학교 산학협력단 당뇨발에 의한 하지 절단 수술의 치료 반응성을 예측하는 방법
CN120089209B (zh) * 2025-05-08 2025-12-05 中国科学院北京基因组研究所(国家生物信息中心) 鉴定肿瘤诱导产生的有核红细胞的方法和装置

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1342794T3 (da) 2002-03-05 2006-04-24 Epigenomics Ag Fremgangsmåde og anordning til at bestemme vævsspecificitet af fritflydende DNA i legemsvæsker
WO2007050706A2 (en) 2005-10-27 2007-05-03 University Of Missouri-Columbia Dna methylation biomarkers in lymphoid and hematopoietic malignancies
US20090176655A1 (en) * 2007-11-16 2009-07-09 Oncomethylome Sciences Sa Methylation detection
US9023819B2 (en) * 2008-06-09 2015-05-05 National Chung Cheng University Treatment of a disease or a condition associated with aberrant gene hypomethylation by a method involving tailored epigenomic modification
US20110028333A1 (en) * 2009-05-01 2011-02-03 Brown University Diagnosing, prognosing, and early detection of cancers by dna methylation profiling
WO2011092592A2 (en) 2010-01-26 2011-08-04 Nipd Genetics Ltd Methods and compositions for noninvasive prenatal diagnosis of fetal aneuploidies
PL2558854T3 (pl) 2010-04-16 2019-04-30 Chronix Biomedical Biomarkery będące krążącymi kwasami nukleinowymi związanymi z rakiem piersi
CN105243295B (zh) 2010-11-30 2018-08-17 香港中文大学 与癌症相关的遗传或分子畸变的检测
US20120190020A1 (en) 2011-01-25 2012-07-26 Aria Diagnostics, Inc. Detection of genetic abnormalities
CN102206708B (zh) * 2011-03-29 2014-05-28 北京大学 一种检测血液中转移肝癌细胞的试剂盒、标志物及方法
US10752953B2 (en) 2011-05-12 2020-08-25 The Johns Hopkins University Method of detecting cancer through generalized loss of stability of epigenetic domains, and compositions thereof
US20140178348A1 (en) 2011-05-25 2014-06-26 The Regents Of The University Of California Methods using DNA methylation for identifying a cell or a mixture of cells for prognosis and diagnosis of diseases, and for cell remediation therapies
CN113355321A (zh) 2011-09-26 2021-09-07 凯杰有限公司 用于分离细胞外核酸的快速方法
EP2768985B1 (en) 2011-10-21 2019-03-20 Chronix Biomedical Colorectal cancer associated circulating nucleic acid biomarkers
US20130122492A1 (en) * 2011-11-14 2013-05-16 Kellbenx Inc. Detection, isolation and analysis of rare cells in biological fluids
SI4056712T1 (sl) * 2012-09-20 2024-10-30 The Chinese University Of Hong Kong Neinvazivno določanje metiloma tumorja iz plazme
US9732390B2 (en) * 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
US20130189684A1 (en) 2013-03-12 2013-07-25 Sequenom, Inc. Quantification of cell-specific nucleic acid markers
US20160340740A1 (en) 2014-01-30 2016-11-24 The Regents Of The University Of California Methylation haplotyping for non-invasive diagnosis (monod)
WO2015159292A2 (en) 2014-04-14 2015-10-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. A method and kit for determining the tissue or cell origin of dna
JP6681841B2 (ja) 2014-05-09 2020-04-15 ライフコーデックス アーゲー 特別な細胞タイプに由来するdnaの検出とそれに関連する方法
KR101598371B1 (ko) * 2014-07-14 2016-02-29 브릴리언츠 주식회사 스마트멀티카드
TWI813141B (zh) 2014-07-18 2023-08-21 香港中文大學 Dna混合物中之組織甲基化模式分析
US10364467B2 (en) 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
EP3885447B1 (en) 2016-05-30 2024-01-10 The Chinese University Of Hong Kong Detecting hematological disorders using cell-free dna in blood

Also Published As

Publication number Publication date
TW201800754A (zh) 2018-01-01
JP2019524056A (ja) 2019-09-05
KR20230164209A (ko) 2023-12-01
KR102482616B1 (ko) 2022-12-28
JP7537758B2 (ja) 2024-08-21
EP3885447B1 (en) 2024-01-10
KR20190013878A (ko) 2019-02-11
DK3464637T3 (da) 2021-07-26
CN115161390B (zh) 2025-12-05
CN115161390A (zh) 2022-10-11
US20200385811A1 (en) 2020-12-10
DK3885447T3 (da) 2024-04-15
IL262953B2 (en) 2023-11-01
EP3885447A1 (en) 2021-09-29
CA3025708A1 (en) 2017-12-07
US20240229103A1 (en) 2024-07-11
US11873527B2 (en) 2024-01-16
EP4324937B1 (en) 2026-01-21
EP4324937A3 (en) 2024-05-15
WO2017206888A1 (en) 2017-12-07
EP4324937A2 (en) 2024-02-21
EP3464637A1 (en) 2019-04-10
US10781490B2 (en) 2020-09-22
AU2017274038A1 (en) 2018-12-06
KR20260023093A (ko) 2026-02-20
TWI838330B (zh) 2024-04-11
IL303115B1 (en) 2025-05-01
AU2017274038B2 (en) 2023-03-16
IL303115B2 (en) 2025-09-01
KR102605504B1 (ko) 2023-11-22
AU2023203305A1 (en) 2023-06-22
EP3464637B1 (en) 2021-06-23
SG11201810544WA (en) 2018-12-28
CN109196120B (zh) 2022-08-02
KR102922179B1 (ko) 2026-02-02
KR20230003666A (ko) 2023-01-06
US20170349948A1 (en) 2017-12-07
JP7819956B2 (ja) 2026-02-25
JP6987393B2 (ja) 2021-12-22
IL262953B1 (en) 2023-07-01
IL303115A (en) 2023-07-01
IL262953A (en) 2018-12-31
EP3464637A4 (en) 2019-12-11
CN109196120A (zh) 2019-01-11
EP4324937C0 (en) 2026-01-21
JP2022024127A (ja) 2022-02-08
JP2024054311A (ja) 2024-04-16
TW202426661A (zh) 2024-07-01

Similar Documents

Publication Publication Date Title
ES3060334T3 (en) Detecting hematological disorders using cell-free dna in blood
HK40060886B (en) Detecting hematological disorders using cell-free dna in blood
HK40081560A (en) Detecting hematological disorders using cell-free dna in blood
HK40060886A (en) Detecting hematological disorders using cell-free dna in blood
HK1262491B (en) Detecting hematological disorders using cell-free dna in blood
HK1261820A1 (en) Detecting hematological disorders using cell-free dna in blood
HK1261820B (en) Detecting hematological disorders using cell-free dna in blood
ES2786778T3 (es) Procedimiento para identificar la composición celular cuantitativa en una muestra biológica
Rabbolini et al. DNA-based diagnosis of uncharacterized inherited macrothrombocytopenias using next-generation sequencing technology with a candidate gene array